Hyderabad Telangana, India

Samala Bhanuchander

This inventor holds 1 USPTO granted patent. Top assignee: Aurobindo Pharma Limited. Active years: 2021.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Samala Bhanuchander

Introduction: Samala Bhanuchander, an accomplished inventor based in Hyderabad, Telangana, India, has made significant contributions to the pharmaceutical industry. With a strong focus on improving processes within drug formulation, Bhanuchander holds a notable patent that showcases his dedication to innovation.

Latest Patents: Bhanuchander’s patent, titled "Process for the preparation of Eltrombopag olamine and its intermediates," presents an improved method for purifying Eltrombopag olamine, a compound of formula (2). This invention also encompasses an advanced procedure for preparing intermediates, which are crucial for the production of Eltrombopag olamine. The patent reflects Bhanuchander's commitment to enhancing pharmaceutical processes and contributing to the improvement of therapeutic options.

Career Highlights: Currently, Samala Bhanuchander works at Aurobindo Pharma Limited, a notable player in the global pharmaceutical market. His tenure at Aurobindo has been marked by a focus on innovative drug development and process optimization, highlighting his expertise in the field.

Collaborations: Bhanuchander has had the opportunity to collaborate with notable colleagues, including Moturu Venkata Ramakrishna Murthy and Tiwari Shashi Kant. Together, they have contributed to advancing their projects, fostering a collaborative environment that enhances the development of innovative pharmaceutical solutions.

Conclusion: Samala Bhanuchander exemplifies the spirit of innovation in the pharmaceutical industry. His patent for an improved process for Eltrombopag olamine not only marks a personal achievement but also contributes to the broader goal of enhancing drug formulations. As he continues to work at Aurobindo Pharma Limited, his future innovations are anticipated to further advance the field and improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…